intranasal glutathione in parkinson& 39 Frontiers Revamping Parkinson's disease therapy using
Revamping Parkinson's disease therapy using PLGA based drug delivery systems npj Parkinson's Disease Nanotechnology based advancements in Parkinson's therapy: Exploring animal models and clinical insights in neurodegenerative disorders ScienceDirect Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties PMC Innovative approach in Parkinson's targeting via berberine loaded mucoadhesive surface modified liposomes: a multi faceted study BMC Pharmacology and Toxicology Springer Nature Link
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



